Risperidone for the Treatment of Huntington's Disease Involuntary Movements

Summary

The purpose of this study is to assess the safety and benefit of risperidone for the treatment of chorea (involuntary movements) in Huntington's disease. Risperidone is commonly used in clinical practice to treat chorea, however, it has not been approved by the Food and Drug Administration (FDA) to treat chorea. This study will examine 1) whether the investigators see MRI changes with risperidone treatment and 2) whether sensors applied to the participants body can measure chorea and detect changes in chorea.

Timeline

Start

2020-08-13

Primary completion

2023-12-30

Completion

2023-12-30

Drugs

Indications